Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model Article (Faculty180)

cited authors

  • Tang, Yuan; Gan, Xiaoliang; Cheheltani, Rabe'e; Curran, Elizabeth; Lamberti, Giuseppina; Krynska, Barbara; Kiani, Mohammad F; Wang, Bin


  • Rebuilding of infarcted myocardium by mesenchymal stem cells (MSCs) has not been successful because of poor cell survival due in part to insufficient blood supply after myocardial infarction (MI). We hypothesize that targeted delivery of vascular endothelial growth factor (VEGF) to MI can help regenerate vasculature in support of MSC therapy in a rat model of MI. VEGF-encapsulated immunoliposomes targeting overexpressed P-selectin in MI tissue were infused by tail vein immediately after MI. One week later, MSCs were injected intramyocardially. The cardiac function loss was moderated slightly by targeted delivery of VEGF or MSC treatment. Targeted VEGF+MSC combination treatment showed highest attenuation in cardiac function loss. The combination treatment also increased blood vessel density (80%) and decreased collagen content in post-MI tissue (33%). Engraftment of MSCs in the combination treatment group was significantly increased and the engrafted cells contributed to the restoration of blood vessels.


publication date

  • 2014

start page

  • 1711

end page

  • 8


  • 10